Your browser doesn't support javascript.
loading
MerTK is a mediator of alpha-synuclein fibril uptake by human microglia.
Dorion, Marie-France; Yaqubi, Moein; Senkevich, Konstantin; Kieran, Nicholas W; MacDonald, Adam; Chen, Carol X Q; Luo, Wen; Wallis, Amber; Shlaifer, Irina; Hall, Jeffery A; Dudley, Roy W R; Glass, Ian A; Stratton, Jo Anne; Fon, Edward A; Bartels, Tim; Antel, Jack P; Gan-Or, Ziv; Durcan, Thomas M; Healy, Luke M.
Afiliação
  • Dorion MF; Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Yaqubi M; Neuroimmunology Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Senkevich K; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Kieran NW; Neuroimmunology Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • MacDonald A; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Chen CXQ; McGill Parkinson Program and Neurodegenerative Diseases Group, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Luo W; Department of Human Genetics, McGill University, Montreal H3A 0C7, Canada.
  • Wallis A; Neuroimmunology Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Shlaifer I; Neuroimmunology Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Hall JA; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Dudley RWR; Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Glass IA; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Stratton JA; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Fon EA; UK Dementia Research Institute, University College London, London WC1E 6BT, UK.
  • Bartels T; Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Antel JP; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Gan-Or Z; Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Durcan TM; Department of Pediatric Surgery, Division of Neurosurgery, Montreal Children's Hospital, McGill University Health Centers, Montreal H4A 3J1, Canada.
  • Healy LM; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Brain ; 147(2): 427-443, 2024 02 01.
Article em En | MEDLINE | ID: mdl-37671615
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doença por Corpos de Lewy / Sinucleinopatias Limite: Humans Idioma: En Revista: Brain Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doença por Corpos de Lewy / Sinucleinopatias Limite: Humans Idioma: En Revista: Brain Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido